Statement: the primary trial reported a combined total of 3 cases of Pericardial effusion, Asthenia and Gastritis in cohort 1.
Primary_evidence: Adverse Events 1:   Total: 20/101 (19.80%)   Neutropenia * 2/101 (1.98%)   Febrile neutropenia * 1/101 (0.99%)   Pericardial effusion * 2/101 (1.98%)   Abdominal distension * 1/101 (0.99%)   Abdominal pain * 1/101 (0.99%)   Ascites * 1/101 (0.99%)   Gastritis * 1/101 (0.99%)   Asthenia * 1/101 (0.99%)   Pyrexia * 1/101 (0.99%)   Pneumonia * 1/101 (0.99%)   Pseudomonal sepsis * 1/101 (0.99%)